13F Holdings
中文EN

LMAT LEMAITRE VASCULAR INC

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1158895 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY11.8%
TTM net income YoY18.7%
TTM EPS YoY18.5%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR32.4%

Margins

Gross margin72.0%
Operating margin27.7%
Net margin23.5%
FCF margin24.9%
EBITDA margin31.7%

Returns

ROE15.6%
ROA10.1%
ROIC (approx.)15.3%
Asset turnover0.43x

Leverage & solvency

Liabilities / assets34.1%
Debt / equity0.00x
Current ratio14.60x
Interest coverage14.35x

Cash quality & payout

Operating cash flow / net income1.20x
Accruals ratio-2.1%
Payout ratio34.2%
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$249.60M$219.86M$193.48M$161.65M$154.42M
Cost of revenue$71.06M$68.96M$66.44M$56.76M$53.04M
Gross profit$178.54M$150.90M$127.05M$104.90M$101.38M
R&D expense$14.14M$15.65M$16.97M$13.29M$11.80M
SG&A expense$42.02M$36.26M$31.83M$28.75M$25.50M
Operating income$67.91M$52.26M$36.71M$26.83M$36.42M
Interest expense$5.18M$205,000$0$0$2.22M
Pretax income$75.18M$56.88M$39.48M$27.49M$34.29M
Income tax$17.45M$12.84M$9.37M$6.85M$7.38M
Net income$57.73M$44.04M$30.11M$20.64M$26.91M
EBITDA$78.33M$61.86M$46.23M$36.26M$47.49M
EPS (basic)2.551.961.360.941.27
EPS (diluted)2.521.931.340.931.25
Dividends declared per share0.800.640.560.500.44
Weighted avg. shares (diluted)22.93M22.78M22.42M22.17M21.48M
Balance sheet
Cash & equivalents$28.24M$25.61M$24.27M$19.13M$13.86M
Short-term investments$330.88M$274.11M$80.81M$63.56M$56.10M
Receivables$33.61M$30.06M$25.06M$22.04M$19.63M
Current assets$468.23M$402.19M$194.60M$161.73M$139.88M
PP&E, net$27.00M$24.80M$21.75M$17.90M$17.06M
Goodwill$65.94M$65.94M$65.94M$65.94M$65.94M
Intangibles$33.09M$35.82M$41.71M$46.53M$52.71M
Total assets$615.69M$551.82M$346.78M$310.48M$292.80M
Current liabilities$36.32M$30.61M$29.88M$25.33M$21.81M
Total liabilities$222.17M$214.53M$48.88M$42.27M$38.65M
Shareholders' equity$393.52M$337.29M$297.90M$268.20M$254.15M
Shares outstanding22.77M22.55M———
Cash flow statement
Operating cash flow$81.25M$44.12M$36.75M$25.38M$35.10M
Capital expenditure$6.78M$6.96M$7.26M$3.23M$4.88M
Free cash flow$74.47M$37.16M$29.49M$22.15M$30.22M
Investing cash flow-$64.94M-$200.12M-$24.71M-$10.37M-$61.08M
Financing cash flow-$14.54M$158.10M-$7.13M-$9.23M$13.70M
Depreciation & amortization$10.42M$9.61M$9.52M$9.43M$11.07M
Stock-based compensation$7.83M$6.57M$5.32M$4.17M$3.48M
Dividends paid$18.11M$14.38M$12.45M$10.99M$9.34M
Share buybacks$1.82M$1.72M$853,000$642,000$802,000

Free plan shows the latest 5 periods; Pro shows all 17 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.